Delafloxacin bulk supplier for pharma manufacturers

Delafloxacin 300mg, 450mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 300mg, 450mg

Reference Brands: BAXDELA (USA), Quofenix (EU/UK)

Delafloxacin tablets (450 mg) and injection are a fluoroquinolone antibiotic for acute skin infections and community-acquired pneumonia, including infections caused by MRSA. Reference brands are Baxdela (US) and Quofenix (EU). Patent status differs by country, so we confirm what can lawfully be supplied to your destination before quoting.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Delafloxacin? List it or send an offer →

Product Description:

Delafloxacin is a fluoroquinolone with an unusual property: it is anionic, where other quinolones are zwitterionic. That charge gives it enhanced potency in acidic environments — abscesses, inflamed skin, infected tissue — where conventional quinolones lose activity. It is also active against methicillin-resistant Staphylococcus aureus, which most fluoroquinolones are not.

It is indicated for acute bacterial skin and skin structure infection and for community-acquired bacterial pneumonia, and is supplied as 450 mg tablets and as powder for injection, with the oral and intravenous doses designed for direct switch.

The fluoroquinolone class warnings apply in full. Regulators including the FDA and EMA have restricted the class following reports of disabling and potentially irreversible tendon, muscle, joint and nervous system effects, together with aortic aneurysm risk. Fluoroquinolones are no longer recommended for uncomplicated infections where alternatives exist. Labelling must carry the current class warnings for the destination market.

Sourcing notes. Delafloxacin is a relatively recent product and patent position varies by territory; verify freedom to operate in the destination market before treating it as genericisable. Registration precedent is narrower than for established quinolones. WHO classifies fluoroquinolones under Watch.

Delafloxacin — third party manufacturing & bulk supply

Delafloxacin 300mg, 450mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Delafloxacin is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Delafloxacin listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Delafloxacin →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

It is active against MRSA and works better in acidic infection sites such as abscesses.

300 mg intravenously or 450 mg by mouth every 12 hours, for 5 to 14 days.

The fluoroquinolone class warnings: tendon rupture, nerve damage, central nervous system effects, aortic aneurysm risk and worsening of myasthenia gravis.